3rd Quarter - Report

EISAI INC. for EISAI INC.

Firm
Client
Income
—
Expenses
$810,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Establishment of pathway for the approval of biosimilars in health reform legislation HR 1427, Promoting Innovation and Access to Life-Saving Medicine Act HR 1548, Pathway for Biosimilars Act S. 369, Preserve Acess to Affordable Generics Act S. 726, Promoting Innovation and Access to Life-Saving Medicine Act

LobbyistCovered position, as disclosed
RAYMOND FROST —
PETER NORMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1548 (111th), H.R. 1427 (111th), S. 726 (111th), S. 369 (111th)

Copyright/Patent/Trademark CPT

Patent Reform Authorized Generics HR 1260, Patent Reform Act of 2009 S. 515, Patent Reform Act of 2009 S. 610, Patent Reform Act of 2009 S. 501, A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs

LobbyistCovered position, as disclosed
RAYMOND FROST —
PETER NORMAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 501 (111th), S. 515 (111th), H.R. 1260 (111th), S. 610 (111th)

Health Issues HCR

Alzheimer's Awareness Health reform Comparative Effectiveness HR 3200, American Affordable Health Choices Act of 2009 Tri Caucus Health Reform bill Senate HELP Committee The Affordable Health Choices Act Baucus/Senate Finance America's Health Future Act of 2009 S. 1110, Medicare Payment Advisory Commission (MedPAC) Reform Act of 2009 HR 2502 Comparative Efectiveness Research Act of 2009 S. 1213. Patient-Centered Outcomes Research Act of 2009 S. 301, Physician Payments Sunshine Act

LobbyistCovered position, as disclosed
RAYMOND FROST —
PETER NORMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1213 (111th), H.R. 2502 (111th), S. 1110 (111th), H.R. 3200 (111th), S. 301 (111th)

Medicare/Medicaid MMM

Medicare non-interference, health reform, Comparative Effectiveness, Alzheimer's Awareness S. Con. Res. 13 H. Con. Res. 85 HR 3200, American Affordable Health Choices Act of 2009 Tri Caucus Health Reform bill Senate HELP Committee The Affordable Health Choices Act Baucus/Senate Finance Committee America's Healthy Future Act of 2009 S. 1110, Medicare Payment Advisory Commission (MedPAC) Reform Act of 2009 HR 2502 Comparative Efectiveness Research Act of 2009 S. 1213. Patient-Centered Outcomes Research Act of 2009 S. 301, Physician Payments Sunshine Act Biosimilars Medicare reimbursement

LobbyistCovered position, as disclosed
RAYMOND FROST —
PETER NORMAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.Con.Res. 85 (111th), S. 301 (111th), H.R. 2502 (111th), H.R. 3200 (111th), S. 1110 (111th), S. 1213 (111th), S.Con.Res. 13 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.